News

Journal of Cellular and Molecular Medicine Publishes Preclinical Data of Panavance’s GP-2250 to treat Pancreatic Cancer

Results showed antineoplastic activity in pancreatic tumor cell lines Metabolic and transcriptional findings demonstrate a molecular basis to reduce tumor...

TNDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead the Tandem Diabetes Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)...

VALBIOTIS SA: Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study: Impressive Efficacy of TOTUM•63 Against Prediabetes and the Early Stages of Type 2 Diabetes, a First for a Non-drug Active Substance

Cloud DX Announces Closing of $3,546,000 Private Placement of Secured Convertible Debentures, and Amendments to Existing Unsecured Convertible Debentures and Warrant Repricing

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

Conservative care private practice owners can leverage Breakthrough's exclusive marketing campaigns to promote Enovis™ Corporation's innovative therapeutic technologies directly to...

error: Content is protected !!